Published in Onderstepoort J Vet Res on December 01, 1993
Exploring reservoir dynamics: a case study of rabies in the Serengeti ecosystem. J Appl Ecol (2008) 1.98
Disease in endangered metapopulations: the importance of alternative hosts. Proc Biol Sci (2002) 1.57
Rabies in Zimbabwe: reservoir dogs and the implications for disease control. Philos Trans R Soc Lond B Biol Sci (1998) 1.31
Domestic dog demographic structure and dynamics relevant to rabies control planning in urban areas in Africa: the case of Iringa, Tanzania. BMC Vet Res (2012) 1.23
Contact with domestic dogs increases pathogen exposure in endangered African wild dogs (Lycaon pictus). PLoS One (2012) 0.88
Rabies virus and canine distemper virus in wild and domestic carnivores in Northern Kenya: are domestic dogs the reservoir? Ecohealth (2013) 0.85
Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Philos Trans R Soc Lond B Biol Sci (2001) 4.68
Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol (1993) 4.13
Inference for nonlinear dynamical systems. Proc Natl Acad Sci U S A (2006) 3.75
Ecological and genetic factors in conservation: a cautionary tale. Science (1994) 2.68
The expression of Streptomyces and Escherichia coli drug-resistance determinants cloned into the Streptomyces phage phi C31. Gene (1983) 2.15
A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries. Vaccine (2003) 1.99
Lattice effects observed in chaotic dynamics of experimental populations. Science (2001) 1.97
Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. J Virol (1992) 1.93
Low-coverage vaccination strategies for the conservation of endangered species. Nature (2006) 1.85
Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report. Neurology (2009) 1.74
Conserving large populations of lions - the argument for fences has holes. Ecol Lett (2013) 1.69
Rabies in African wild dogs (Lycaon pictus) in the Serengeti region, Tanzania. J Wildl Dis (1993) 1.65
Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc Natl Acad Sci U S A (1993) 1.60
Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol (2002) 1.52
Rabies and mortality in Ethiopian wolves (Canis simensis). J Wildl Dis (1996) 1.49
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol (2003) 1.48
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol (2001) 1.38
Viral contamination of foetal bovine serum. Vet Rec (1975) 1.30
[Parasitism of Mustelidae by Skrjabingylus petrovi: first report in western Europe]. Ann Parasitol Hum Comp (1986) 1.22
Prevalence of zoonotic important parasites in the red fox (Vulpes vulpes) in Great Britain. Vet Parasitol (2003) 1.22
Molecular epidemiology identifies only a single rabies virus variant circulating in complex carnivore communities of the Serengeti. Proc Biol Sci (2007) 1.20
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Ann Oncol (2009) 1.20
Development of a hemi-nested RT-PCR method for the specific determination of European Bat Lyssavirus 1. Comparison with other rabies diagnostic methods. Vaccine (2004) 1.17
Ten-year survey of British bats for the existence of rabies. Vet Rec (1996) 1.15
Hypoglycemia in Beckwith-Wiedemann syndrome. Semin Perinatol (2000) 1.15
Use of filter paper (FTA) technology for sampling, recovery and molecular characterisation of rabies viruses. J Virol Methods (2006) 1.13
The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol (1986) 1.12
The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. Vaccine (2007) 1.07
Persistence and transmission of tick-borne viruses: Ixodes ricinus and louping-ill virus in red grouse populations. Parasitology (1995) 1.06
Incidence and persistence of classical swine fever in free-ranging wild boar (Sus scrofa). Epidemiol Infect (2005) 1.03
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study. Br J Cancer (2005) 1.00
Safety and efficacy of the oral rabies vaccine SAG2 in raccoon dogs. Vaccine (2006) 1.00
The expression of the Escherichia coli lacZ gene in Streptomyces. J Gen Microbiol (1986) 0.97
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration. Eur J Cancer (2002) 0.95
Comparison of the efficacy of the antirabies vaccines used for foxes in France. Vet Res (1996) 0.95
The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology (2006) 0.95
Infection of foxes by Echinococcocus multilocularis in urban and suburban areas of Nancy, France: influence of feeding habits and environment. Parasite (2008) 0.94
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study. Ann Oncol (2000) 0.94
Environmental and human influence on the ecology of Trichinella spiralis and Trichinella britovi in Western Europe. Parasitology (1996) 0.94
Efficacy and bait acceptance of vaccinia vectored rabies glycoprotein vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris). Vaccine (2008) 0.93
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial. Br J Cancer (2004) 0.93
Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388D1). J Gen Virol (1984) 0.92
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report. Eur J Cancer (2001) 0.92
Population pharmacokinetics of quinidine. Br J Clin Pharmacol (1991) 0.92
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Ann Oncol (1998) 0.91
The demonstration of maedi/visna virus in sheep in Great Britain. Vet Rec (1979) 0.90
Bat rabies surveillance in France, from 1989 through May 2005. Dev Biol (Basel) (2006) 0.90
Molecular genetic and morphological analyses of the African wild dog (Lycaon pictus). J Hered (1994) 0.90
Epidemiology of rabid bats in France, 1989 to 2002. Vet Rec (2004) 0.90
Localization of the genetic locus for Saethre-Chotzen syndrome to a 6 cM region of chromosome 7 using four cases with apparently balanced translocations at 7p21.2. Hum Mol Genet (1994) 0.89
Fox defecation behaviour in relation to spatial distribution of voles in an urbanised area: An increasing risk of transmission of Echinococcus multilocularis? Int J Parasitol (2010) 0.88
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol (1999) 0.88
Maternal smoking and birth weight in relation to dietary habits. Am J Obstet Gynecol (1982) 0.87
SAG-2 oral rabies vaccine. Onderstepoort J Vet Res (1993) 0.87
Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France. Curr Top Microbiol Immunol (1994) 0.87
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Ann Oncol (2012) 0.87
[Listeriosis in obstetrical environment. Report on 10-year experience in a maternity hospital in Paris]. J Gynecol Obstet Biol Reprod (Paris) (1986) 0.87
Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe. Vaccine (1996) 0.86
Measurement of plasma human chorionic gonadotropin (hCG) and beta-hCG activities in the late luteal phase: evidence of the occurrence of spontaneous menstrual abortions in infertile women. Fertil Steril (1979) 0.85
Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies. Vet Rec (1997) 0.85
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol (2000) 0.84
[Transmissibility and pathogenicity in the red fox of two rabies viruses isolated at a 10 year interval]. Ann Rech Vet (1991) 0.84
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer. Ann Oncol (1999) 0.84
Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison. Vaccine (1992) 0.84
[Appendiceal endometriosis disclosed by pregnancy]. Med Chir Dig (1980) 0.83
[The bioavailability of natural progesterone given by mouth. Measurement of steroid concentrations in plasma, endometrium and breast tissue]. J Gynecol Obstet Biol Reprod (Paris) (1982) 0.83
A rabies serosurvey of domestic dogs in rural Tanzania: results of a rapid fluorescent focus inhibition test (RFFIT) and a liquid-phase blocking ELISA used in parallel. Epidemiol Infect (1999) 0.82
[Echocardiography study of hemodynamic changes in pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (1984) 0.82
Means used for terrestrial rabies elimination in France and policy for rabies surveillance in case of re-emergence. Dev Biol (Basel) (2006) 0.82
Border disease of sheep. Comparison of the results of serological testing using complement fixation, immunodiffusion, neutralization and immunofluorescent techniques. Br Vet J (1975) 0.82
[Analgesic effect of ibuprofen in pain after episiotomy]. Ann Fr Anesth Reanim (1992) 0.82
Anthrax outbreak in Mago National Park, southern Ethiopia. Vet Rec (2002) 0.82
Efficacy of SAD (Berne) rabies vaccine given by the oral route in two species of jackal (Canis mesomelas and Canis adustus). J Wildl Dis (1995) 0.81
Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab. Ann Oncol (2007) 0.81
[Dystocia at the onset of labour. An evaluation of the different treatments available (author's transl)]. J Gynecol Obstet Biol Reprod (Paris) (1981) 0.81
Serological survey of herpesvirus infections in wild ruminants of France and Belgium. J Wildl Dis (1988) 0.81
Embryology of dolphins. Staging and ageing of embryos and fetuses of some cetaceans. Adv Anat Embryol Cell Biol (2000) 0.81
Border disease of sheep: isolation of the virus in tissue culture and experimental reproduction of the disease. Vet Rec (1977) 0.81
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study. Eur J Cancer (2004) 0.80
Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non-target species. Vet Res (1999) 0.80
Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine. Vaccine (2001) 0.80
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial. Eur J Cancer (2001) 0.80
Major histocompatibility complex diversity in the endangered Ethiopian wolf (Canis simensis). Tissue Antigens (2011) 0.80
Grover's disease induced by cetuximab. Dermatology (2006) 0.79
Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. Eur J Clin Invest (1988) 0.79
First oral vaccination of wildlife against rabies in Estonia. Dev Biol (Basel) (2006) 0.79
Infectious canine hepatitis in red foxes (Vulpes vulpes) in the United Kingdom. Vet Rec (2010) 0.78
Identification of sylvatic Trichinella (T3) in foxes from France. Vet Parasitol (1991) 0.78
African horse sickness and African carnivores. Vet Microbiol (1995) 0.78
New strains of rabies-related viruses isolated from bats in the Ukraine. Acta Virol (1991) 0.78
Rabies in the Masai Mara, Kenya: preliminary report. Onderstepoort J Vet Res (1993) 0.78
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study. Eur J Cancer (2002) 0.78
Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression? Hum Reprod (1986) 0.78
Genetic analysis of European bat lyssavirus type 1 isolates from France. Vet Rec (2004) 0.78
Oral bioavailability of mesna tablets. Cancer Chemother Pharmacol (1993) 0.78
Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG2 and V-RG vaccines. Vaccine (2001) 0.78
[Detection of a new herpesvirus in a unusual case of Pacheco's parrot disease in Amazonian and gray parrots]. Zentralbl Veterinarmed B (1988) 0.77
[Acute upper genital tract infections. II. A. bacteriological study and the therapeutic consequences]. J Gynecol Obstet Biol Reprod (Paris) (1980) 0.77
Immunological assessment of exposure to Echinococcus granulosus in a rural dog population in Uruguay. Acta Trop (1994) 0.77